These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
156 related articles for article (PubMed ID: 30337701)
1. Cumulative dosages of chemotherapy and radiotherapy exposure, and risk of secondary malignancies after allogeneic hematopoietic stem cell transplantation. Ziegler AK; Abend M; Port M; Dammann E; Homeyer RS; Eder M; Ganser A; Schrem H; Koenecke C Bone Marrow Transplant; 2019 Apr; 54(4):635-640. PubMed ID: 30337701 [No Abstract] [Full Text] [Related]
2. Second malignancies after allogeneic stem cell transplantation with reduced-intensity conditioning: is the incidence reduced? Shimoni A Biol Blood Marrow Transplant; 2014 Nov; 20(11):1669-70. PubMed ID: 25223487 [No Abstract] [Full Text] [Related]
3. Allogeneic transplantation in multiple myeloma: a potential renaissance in the era of novel therapies? Richardson P Biol Blood Marrow Transplant; 2014 Aug; 20(8):1078-9. PubMed ID: 24956499 [No Abstract] [Full Text] [Related]
4. Inflammatory bowel disease after allogeneic stem cell transplantation. Boussen I; Sokol H; Aractingi S; Georges O; Hoyeau-Idrissi N; Hugot JP; Mohty M; Rubio MT Bone Marrow Transplant; 2015 Oct; 50(10):1365-6. PubMed ID: 26052914 [No Abstract] [Full Text] [Related]
5. Hyposplenic changes and pseudo-Pelger-Huët anomaly following allogeneic stem cell transplantation. Mohamed M; He SZ Br J Haematol; 2017 Jan; 176(2):155. PubMed ID: 27723081 [No Abstract] [Full Text] [Related]
6. Prevalence of self-reported sleep dysfunction before allogeneic hematopoietic cell transplantation. D'Souza A; Millard H; Knight J; Brazauskas R; Lee SJ; Flynn KE; Rizzo JD; Shaw BE Bone Marrow Transplant; 2018 Aug; 53(8):1079-1082. PubMed ID: 29515251 [No Abstract] [Full Text] [Related]
7. Less mucositis toxicity after 6 versus 3 fractions of high-dose total body irradiation before allogeneic stem cell transplantation. Sengeløv H; Petersen PM; Fog L; Schmidt M; Specht L Bone Marrow Transplant; 2019 Aug; 54(8):1369-1371. PubMed ID: 30718801 [No Abstract] [Full Text] [Related]
8. Gut decontamination during allogeneic hematopoietic stem cell transplantation and the risk of acute graft-versus-host disease. Gjærde LK; Schmidt M; Sengeløv H Bone Marrow Transplant; 2018 Aug; 53(8):1061-1064. PubMed ID: 29491465 [No Abstract] [Full Text] [Related]
9. Incidence of second cancers after allogeneic hematopoietic stem cell transplantation using reduced-dose radiation. Hsieh MM; Fitzhugh CD; Tisdale JF Blood; 2009 Jul; 114(1):225; author reply 225-6. PubMed ID: 19574484 [No Abstract] [Full Text] [Related]
11. Total body irradiation is a crucial risk factor for developing secondary carcinomas after allogeneic hematopoietic stem cell transplantation in childhood. Keslova P; Formankova R; Riha P; Sramkova L; Snajderova M; Malinova B; Luks A; Sterba J; Stary J; Sedlacek P Neoplasma; 2020 Sep; 67(5):1164-1169. PubMed ID: 32657609 [TBL] [Abstract][Full Text] [Related]
12. Second allogeneic stem cell transplantation using nonmyeloablative conditioning for patients who relapsed or developed secondary malignancies following autologous transplantation. Nagler A; Or R; Naparstek E; Varadi G; Slavin S Exp Hematol; 2000 Sep; 28(9):1096-104. PubMed ID: 11008023 [TBL] [Abstract][Full Text] [Related]
13. Clinicopathologic characteristics of secondary squamous cell carcinoma of head and neck in survivors of allogeneic hematopoietic stem cell transplantation for hematologic malignancies. Chaulagain CP; Sprague KA; Pilichowska M; Cowan J; Klein AK; Kaul E; Miller KB Bone Marrow Transplant; 2019 Apr; 54(4):560-566. PubMed ID: 30127467 [TBL] [Abstract][Full Text] [Related]